Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copper-dependent enzymes (cuproenzymes) are a diverse group of enzymes that require copper ions as essential cofactors for catalytic activity in biological systems[5][14][15]. These enzymes play key roles in a variety of physiological processes such as cellular respiration (cytochrome c oxidase), antioxidant defense (superoxide dismutase), formation of connective tissue (lysyl oxidase), iron metabolism (ceruloplasmin, hephaestin), neurotransmitter synthesis (dopamine beta-hydroxylase, peptidylglycine alpha-amidating mono-oxygenase), and pigment production (tyrosinase)[15]. Copper ions within these enzymes participate directly in redox reactions, electron transport, and substrate transformation. Disorders of copper homeostasis can cause dysfunction of these enzymes and are associated with multiple diseases, but "Copper cofactor enzymes" does not designate a specific molecular target suitable for direct pharmacological intervention as a singular entity[5][14][15].
Chelation (for copper chelators); Enzyme inhibition or modulation (if a given drug targets a specific enzyme in the class, e.g., tyrosinase inhibitors)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper-dependent enzyme.